1. Oncology Clinical Trials Market – Overview
1.1 Definitions and Scope
2. Oncology Clinical Trials Market – Executive Summary
2.1 Market Revenue, Market Size and Key Trends
2.2 Key trends by Phase
2.3 Key trends by Design
2.4 Key trends by Cancer Type
2.5 Key trends by Geography
3. Oncology Clinical Trials Market – Comparative Analysis
3.1 Company Benchmarking – Key Companies
3.2 Financial Analysis– Key Companies
3.3 Market Share Analysis– Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis- Average Selling Price
4. Oncology Clinical Trials Market – Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters Five Force Model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. Oncology Clinical Trials Market – Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. Oncology Clinical Trials Market – By Phase (Market Size –$Million/$Billion)
6.1 Phase I
6.2 Phase II
6.3 Phase III
6.4 Phase IV
7. Oncology Clinical Trials Market – By Design (Market Size –$Million/$Billion)
7.1 Treatment Studies
7.2 Observational Studies
7.3 Interventional
7.4 Expanded Access
8. Oncology Clinical Trials Market – By Cancer Type (Market Size –$Million/$Billion)
8.1 Lung Cancer
8.2 Breast Cancer
8.3 Thyroid Cancer
8.4 Leukemia
8.5 Liver Cancer
8.6 Skin Cancer
8.7 Others
9. Oncology Clinical Trials Market – By Geography (Market Size –$Million/$Billion)
9.1 North America
9.1.1 U.S.
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 U.K.
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Russia
9.2.7 Rest of Europe
9.3 Asia-Pacific
9.3.1 China
9.3.2 India
9.3.3 Japan
9.3.4 South Korea
9.3.5 Australia & New Zealand
9.3.6 Rest of Asia-Pacific
9.4 South America
9.4.1 Brazil
9.4.2 Argentina
9.4.3 Rest of South America
9.5 Rest of the World
9.5.1 Middle East
9.5.2 Africa
10. Oncology Clinical Trials Market – Entropy
11. Oncology Clinical Trials Market Company Analysis
11.1 Company 1
11.2 Company 2
11.3 Company 3
11.4 Company 4
11.5 Company 5
11.6 Company 6
11.7 Company 7
11.8 Company 8
11.9 Company 9
11.10 Company 10
IndustryARC
I 기본 3,500,000원부터~
Report Description
Overview
종양학 임상 시험 시장은 암 치료제와 치료법 개발을 위한 연구 활동을 지원합니다. 이 시장은 새로운 치료제의 수요 증가와 정부 및 민간 투자 확대에 힘입어 지속적으로 성장하고 있습니다.
Segment
임상 시험 단계는 Phase I에서 Phase IV로 구분되며, 설계 방식은 치료 연구, 관찰 연구, 중재 연구 등이 포함됩니다. 주요 암 유형으로는 폐암, 유방암, 갑상선암, 백혈병 등이 있으며, 지역적으로는 북미와 아시아 태평양 지역이 주요 시장입니다.
Key Takeaways
이 시장은 면역 치료제와 개인 맞춤형 암 치료 연구로 인해 혁신을 이루고 있습니다. 또한, 디지털 플랫폼과 데이터 분석의 활용 증가로 임상 시험 관리의 효율성이 높아지며, 신약 개발 속도가 빨라지고 있습니다.